Immunogen | IMGN - Przychody Ze Sprzedaży



Obroty Zmiana Data
AbbVie USD 16.99B 1.99B 2026-06
Agios Pharmaceuticals USD 44.74M 25.94M 2026-06
Amgen USD 10.1B 1.48B 2026-06
Astellas Pharma JPY 640.91B 102.98B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Exelixis USD 628.69M 17.89M 2026-06
Halozyme Therapeutics USD 481M 104M 2026-06
Heron Therapeutics USD 40.59M 2.38M 2025-12
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 13.11B 750M 2026-03
Pfizer USD 15.03B 530M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 12.14B 65M 2026-03